ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Prostatic Cancer
Esophageal Cancer

Adenocarcinoma trials near Kansas City, KS, USA:

Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma

To evaluate the antitumor activity and safety/tolerability of the combination (mFOLFOX + Pembrolizumab) in patients with potentially resectable adenocarcinoma...

Active, not recruiting
Adenocarcinoma
Gastro Esophageal Junction Cancer
Drug: Adjuvant Treatment - mFOLFOX & Pembrolizumab
Drug: Neoadjuvant Treatment - mFOLFOX6 & Pembrolizumab

Phase 2

University of Kansas
University of Kansas

Westwood, Kansas, United States

(nal-IRI), leucovorin, and fluorouracil (5-FU) for treatment of participants with histologically confirmed metastatic pancreatic ductal adenocarcinoma...

Active, not recruiting
Pancreatic Ductal Adenocarcinoma
Drug: Nanoliposomal irinotecan
Drug: Leucovorin

Phase 2

Cardiff Oncology

Westwood, Kansas, United States and 5 other locations

for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for ...

Active, not recruiting
Pancreas Adenocarcinoma
Drug: Gemcitabine
Drug: nab paclitaxel

Phase 3

NovoCure
NovoCure

Kansas City, Missouri, United States and 197 other locations

The study population is advanced gastric, gastroesophageal, and esophageal adenocarcinoma participants who have failed upfront standard of c...

Active, not recruiting
Esophagus Cancer, Adenocarcinoma
Stomach Cancer, Adenocarcinoma
Drug: Rucaparib
Drug: Nivolumab

Phase 1, Phase 2

University of Kansas
University of Kansas

Kansas City, Kansas, United States and 7 other locations

This trial examines how Pancreatic Adenocarcinoma reacts to the addition of 9-ING-41 and retifanlimab to the standard of care chemotherapy t...

Active, not recruiting
Pancreatic Adenocarcinoma
Drug: Gemcitabine
Drug: 9-ING-41

Phase 2

Anwaar Saeed

Fairway, Kansas, United States and 1 other location

The purpose of this study is to evaluate the efficacy of zolbetuximab plus capecitabine and oxaliplatin (CAPOX) compared with placebo plus CAPOX (as...

Active, not recruiting
Metastatic Gastric Adenocarcinoma or Cancer
Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Drug: oxaliplatin
Drug: capecitabine

Phase 3

Astellas
Astellas

Fairway, Kansas, United States and 164 other locations

participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...

Enrolling
Endometrial Adenocarcinoma
Urothelial Carcinoma
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

Kansas City, Missouri, United States and 67 other locations

and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma...

Enrolling
Gastroesophageal Junction Cancer
Gastric Cancer
Drug: Apatinib
Drug: Ramucirumab+ paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Kansas City, Missouri, United States and 149 other locations

The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for ca...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

Phase 3

Ipsen
Ipsen

Kansas City, Missouri, United States and 199 other locations

The ProVent study is a randomized, open-label study designed to assess the efficacy of sipuleucel-T in reducing the progression of lower risk non-met...

Active, not recruiting
Adenocarcinoma of the Prostate
Biological: sipuleucel-T

Phase 3

Dendreon

Overland Park, Kansas, United States and 55 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems